PNP Therapeutics
Latest round
- Series B
Last raised
- May 2012
Total raised
- $1.9M
Investors
- 1
About PNP Therapeutics
PNP Therapeutics, Inc.Established in 2000 in Birmingham, US, PNP Therapeutics, Inc. specializes in cancer therapeutics.67 mn from Greer Capital on May 14, 2012.PNP Therapeutics, Inc. is primarily focused on the development of Gedeptin®, a platform technology designed for cancer treatment. Gedeptin® operates by utilizing a proprietary approach that targets tumor cells, aiming to enhance therapeutic efficacy while minimizing harm to surrounding healthy tissues. The company’s technology has progressed through clinical trials, achieving Orphan Drug Status by the FDA, underscoring its potential in addressing rare cancer indications., granting exclusive rights to its Gedeptin® technology. This agreement enables PNP to generate revenue through licensing fees and potential milestone payments associated with the advancement of Gedeptin® in clinical development. Revenue transactions typically occur on a business-to-business basis with partners in the pharmaceutical industry and are structured to include upfront fees, royalties based on sales, and milestone payments tied to regulatory approvals or sales targets.In May 2012, PNP Therapeutics, Inc. The company is focused on expanding its reach in oncology by developing new therapeutic products utilizing the Gedeptin® technology. Plans for future growth include targeting new geographical markets in Europe and Asia by 2025, which are expected to significantly impact cancer treatment accessibility.
Who invested in PNP Therapeutics
1 investor across 3 rounds
See all investors in PNP Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about PNP Therapeutics
Who invested in PNP Therapeutics?
PNP Therapeutics has 1 investor on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PNP Therapeutics raised?
PNP Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did PNP Therapeutics last raise money?
PNP Therapeutics's most recent round on record is a Series B, in May 2012.
What does PNP Therapeutics do?
PNP Therapeutics is a biotechnology company.
Where is PNP Therapeutics headquartered?
PNP Therapeutics is headquartered in Birmingham, US.
Which VCs invest in companies like PNP Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at PNP Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like PNP Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.